The high-handed rejection of a treatment for Huntington’s disease shows why the biologics chief had to go.
Source link
About The Author
Opinion | Vinay Prasad Is Out at the FDA—Again
The high-handed rejection of a treatment for Huntington’s disease shows why the biologics chief had to go.
Source link